Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Drug Withdrawal Symptoms

cabergoline has been researched along with Drug Withdrawal Symptoms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jensen, TS; Jørgensen, JO; Kallestrup, MM; Kasch, H; Nielsen, E; Østerby, T1
Higuchi, H; Sugawara, Y; Yoshida, K1

Other Studies

2 other study(ies) available for cabergoline and Drug Withdrawal Symptoms

ArticleYear
Prolactinoma-associated headache and dopamine agonist treatment.
    Cephalalgia : an international journal of headache, 2014, Volume: 34, Issue:7

    Topics: Adult; Aminoquinolines; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Headache; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Recurrence; Substance Withdrawal Syndrome

2014
Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants.
    Pharmacopsychiatry, 2006, Volume: 39, Issue:3

    Topics: Adult; Antidepressive Agents, Tricyclic; Cabergoline; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Female; Fluvoxamine; Humans; Imipramine; Substance Withdrawal Syndrome; Treatment Outcome

2006